1. Home
  2. AUPH vs CNOB Comparison

AUPH vs CNOB Comparison

Compare AUPH & CNOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • CNOB
  • Stock Information
  • Founded
  • AUPH 1993
  • CNOB 1982
  • Country
  • AUPH Canada
  • CNOB United States
  • Employees
  • AUPH N/A
  • CNOB N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • CNOB Major Banks
  • Sector
  • AUPH Health Care
  • CNOB Finance
  • Exchange
  • AUPH Nasdaq
  • CNOB Nasdaq
  • Market Cap
  • AUPH 1.4B
  • CNOB 1.2B
  • IPO Year
  • AUPH 1999
  • CNOB 1996
  • Fundamental
  • Price
  • AUPH $12.22
  • CNOB $24.08
  • Analyst Decision
  • AUPH Strong Buy
  • CNOB Buy
  • Analyst Count
  • AUPH 4
  • CNOB 1
  • Target Price
  • AUPH $12.25
  • CNOB $31.00
  • AVG Volume (30 Days)
  • AUPH 2.8M
  • CNOB 341.1K
  • Earning Date
  • AUPH 07-31-2025
  • CNOB 07-29-2025
  • Dividend Yield
  • AUPH N/A
  • CNOB 3.02%
  • EPS Growth
  • AUPH N/A
  • CNOB N/A
  • EPS
  • AUPH 0.42
  • CNOB 0.80
  • Revenue
  • AUPH $260,111,000.00
  • CNOB $241,854,000.00
  • Revenue This Year
  • AUPH $12.15
  • CNOB $46.52
  • Revenue Next Year
  • AUPH $18.34
  • CNOB $29.92
  • P/E Ratio
  • AUPH $29.06
  • CNOB $29.91
  • Revenue Growth
  • AUPH 25.59
  • CNOB N/A
  • 52 Week Low
  • AUPH $6.23
  • CNOB $20.61
  • 52 Week High
  • AUPH $12.53
  • CNOB $29.31
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 78.39
  • CNOB 53.52
  • Support Level
  • AUPH $11.18
  • CNOB $22.54
  • Resistance Level
  • AUPH $11.69
  • CNOB $24.61
  • Average True Range (ATR)
  • AUPH 0.60
  • CNOB 0.65
  • MACD
  • AUPH 0.12
  • CNOB 0.11
  • Stochastic Oscillator
  • AUPH 91.61
  • CNOB 79.13

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About CNOB ConnectOne Bancorp Inc.

ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.

Share on Social Networks: